{"slug":"ara-290-gabapentin-lyrica","title":"ARA-290 vs Gabapentin and Lyrica: Human Trial Data on Nerve Repair Versus Signal Suppression","body":"## Regeneration vs degeneration — where this fits\nNerves can break down after injury or disease. When breakdown exceeds repair, numbness, pain, and loss of function persist. Gabapentin and pregabalin bind calcium channels and lower pain signal strength. ARA-290 research examines whether small nerve fibers can regrow after damage.\n\n## What it is\nARA-290 is a peptide studied in human trials for small-fiber neuropathy and related nerve conditions. Gabapentin and pregabalin (Lyrica) are drugs that act on nerve signaling to reduce pain perception. The comparison centers on repair versus signal suppression.\n\n## How it works\nGabapentinoids attach to the α2δ subunit of calcium channels. This reduces neurotransmitter release and dampens pain signals. ARA-290 is described as activating the innate repair receptor. One 2025 paper states it inhibits NLRP3 inflammasome activation after nerve injury (source s10). Human trial reports note increased corneal nerve fiber density after 28 days of use (source s2).\n\n## Why it would work (logic chain)\nIf inflammation blocks repair, lowering that inflammation could allow regrowth. If the innate repair receptor promotes healing signals, activating it could shift tissue from damage mode to repair mode. If corneal nerve fibers increase, similar changes might occur in other small-fiber areas. Signal suppression alone does not rebuild tissue; repair pathways would need to be active for structural change.\n\n## Why people take it\nPeople seek options when standard drugs do not fully control symptoms or when they want to address underlying nerve changes. Some report using ARA-290 while lowering gabapentin intake. Others try it after side effects from pregabalin or gabapentin.\n\n## How many people take it\nThe ledger contains seven Reddit posts and two other anecdote sources. No total population count exists in the sources. Clinical trial enrollment numbers are not reported here.\n\n## Evidence inventory\n13 studies catalogued. 3 human claims. 5 preclinical claims. 11 anecdotal claims. 7 Reddit posts. 0 X posts. 2 other anecdote sources. Human data come from sarcoidosis and type 2 diabetes trials. Preclinical data include mechanism papers on nerve injury models. Anecdotal reports describe symptom changes and medication adjustments.\n\n## What scientists say\nA 2017 review states that in sarcoidosis patients ARA-290 improved neuropathic and autonomic symptoms and initiated regrowth of small nerve fibers in the cornea (source s2). A phase 2 trial in type 2 diabetes reported better PainDetect scores and improved HbA1c after 28 days (source s3). A 2025 paper links ARA-290 to NLRP3 inhibition in sciatic nerve injury models (source s10). Reviews note that current drugs focus on symptom relief while ARA-290 research targets repair (source s21).\n\n## What people say on Reddit\nOne user on r/smallfiberneuropathy wrote: \"So far, so good and my dosage for gabapentin, has gone down from 2400 mg/day to 800-1600 mg/day ... I am now completely off gabapentin\" (source s5). Another stated: \"I am almost done with a month of ara 290 ... I've tried everything you can imagine, from red light therapy, acupuncture, deep tissue massages, pregabalin, gabapentin etc.\" and reported \"really great results\" (source s17). A third user with disc herniation pain said they started ARA-290 after pregabalin caused light-headedness; after less than one week they noted no benefits or side effects (source s18). One comment reported no improvement after several months (source s19). Posts mention cost as a factor compared with standard medications.\n\n## What people say on X\nNo X posts appear in the ledger.\n\n## What we do not know\nLong-term outcomes beyond 28 days are not detailed in the listed sources. Direct head-to-head trials measuring nerve fiber regrowth against gabapentin or pregabalin are not present. Optimal duration and response rates across different neuropathies remain unquantified here. Individual variation in results is noted in anecdotes but not measured in controlled counts.\n\n## Safety and limits\nGabapentin and pregabalin list dizziness and somnolence in over 20 percent of users, with confusion and edema also reported (source s4). ARA-290 trial summaries do not list comparable side-effect frequencies in the ledger. Anecdotal posts mention no side effects in some cases and early discontinuation in others. The ledger contains no population-level adverse event data.","register":"source_ledger","tags":["peptide","topic"],"category":null,"style":{},"claims":[{"id":"c1","text":"Gabapentin and pregabalin bind to the α2δ subunit of voltage-gated calcium channels, reducing neurotransmitter release and dampening nerve signal transmission.","section":"Overview of Mechanisms","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes suppression mechanism baseline"},{"id":"c2","text":"ARA-290 selectively activates the innate repair receptor (IRR) leading to reported increases in corneal nerve fiber density in human sarcoidosis neuropathy trials.","section":"mechanism","tier":"human","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Core evidence of repair versus masking"},{"id":"c3","text":"In a Phase 2 human trial of 49 adults with type 2 diabetes, 28 days of ARA-290 4 mg daily improved PainDetect neuropathic symptom scores versus placebo.","section":"what_is_known","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Quantified symptom change in controlled setting"},{"id":"c4","text":"No human data exist on direct head-to-head efficacy or safety comparison of ARA-290 versus gabapentin or pregabalin.","section":"Evidence Limitations","tier":"speculative","source_ids":[],"source_status":"unsourced","why_material":"States absence of comparative evidence plainly"},{"id":"c5","text":"Commercial vendors and clinics market this compound (13 commercial/clinic sources catalogued) — marketing material, not evidence.","section":"what_is_known","tier":"human","source_ids":["s4","s7","s9","s12","s16","s22","s24","s5","s6","s15","s17","s18","s19"],"source_status":"sourced","why_material":"Collapsed 10 duplicate marketing claims"},{"id":"c6","text":"User anecdotal report on r/smallfiberneuropathy describing reduced and eventual cessation of gabapentin while using ARA-290 protocol, with positive symptom improvements noted.","section":"who_claims_what","tier":"anecdotal","source_ids":["s5"],"source_status":"sourced","why_material":"Materialized from orphan source s5 by ledger repair"},{"id":"c7","text":"Recent (2025) Reddit discussion in r/neuropathy on ARA-290 for neuropathy, including user experiences with dosing alongside gabapentin for allodynia control.","section":"who_claims_what","tier":"anecdotal","source_ids":["s6"],"source_status":"sourced","why_material":"Materialized from orphan source s6 by ledger repair"},{"id":"c9","text":"Integrative neurology site discusses ARA-290 as potential adjunct to gabapentinoids like gabapentin and pregabalin (Lyrica) for neuropathy, emphasizing regenerative vs symptomatic effects.","section":"what_is_known","tier":"human","source_ids":["s8"],"source_status":"sourced","why_material":"Materialized from orphan source s8 by ledger repair"},{"id":"c11","text":"2025 PubMed paper on ARA290 mechanism for nerve injury repair via NLRP3 inhibition.","section":"mechanism","tier":"mechanistic","source_ids":["s10"],"source_status":"sourced","why_material":"Materialized from orphan source s10 by ledger repair"},{"id":"c12","text":"Review discussing ARA290 vs standard treatments like gabapentin in neuropathy context.","section":"mechanism","tier":"human","source_ids":["s11"],"source_status":"sourced","why_material":"Materialized from orphan source s11 by ledger repair"},{"id":"c14","text":"Anecdotal report on ARA-290 effects, mentions cost vs standard meds.","section":"who_claims_what","tier":"anecdotal","source_ids":["s13"],"source_status":"sourced","why_material":"Materialized from orphan source s13 by ledger repair"},{"id":"c15","text":"Recent anecdotal user experience with ARA-290 for neuropathy pain.","section":"who_claims_what","tier":"anecdotal","source_ids":["s14"],"source_status":"sourced","why_material":"Materialized from orphan source s14 by ledger repair"},{"id":"c16","text":"Video discussing ARA-290 trials and comparison to GABA analogs like Neurontin/Lyrica.","section":"who_claims_what","tier":"anecdotal","source_ids":["s15"],"source_status":"sourced","why_material":"Materialized from orphan source s15 by ledger repair"},{"id":"c18","text":"User reports great results from one month of ARA-290 (non-trial, self-sourced, ~$500 cost), contrasting with ineffective pregabalin/gabapentin and other treatments for neuropathy; plans longer protocol with no side effects noted.","section":"who_claims_what","tier":"anecdotal","source_ids":["s17"],"source_status":"sourced","why_material":"Materialized from orphan source s17 by ledger repair"},{"id":"c19","text":"User with disc-related neuropathic pain (neck/arm) starting ARA-290 protocol (3.3-6mg/day) after pregabalin caused severe light-headedness; early update shows no benefits or side effects after <1 week.","section":"who_claims_what","tier":"anecdotal","source_ids":["s18"],"source_status":"sourced","why_material":"Materialized from orphan source s18 by ledger repair"},{"id":"c20","text":"User comment reports no improvement from ARA-290 after several months of use for (implied) small fiber neuropathy.","section":"who_claims_what","tier":"anecdotal","source_ids":["s19"],"source_status":"sourced","why_material":"Materialized from orphan source s19 by ledger repair"},{"id":"c21","text":"Compares ARA-290 favorably as a regenerative alternative to symptomatic treatments like Gabapentin or Lyrica, citing trial data on pain reduction and nerve repair.","section":"who_claims_what","tier":"anecdotal","source_ids":["s20"],"source_status":"sourced","why_material":"Materialized from orphan source s20 by ledger repair"},{"id":"c22","text":"2025 review discusses ARA-290 benefits in diabetic neuropathy alongside limitations of standard anticonvulsants like gabapentinoids.","section":"what_is_known","tier":"human","source_ids":["s21"],"source_status":"sourced","why_material":"Materialized from orphan source s21 by ledger repair"},{"id":"c24","text":"2026 guide contrasts ARA-290's regenerative mechanism with symptom-masking drugs like gabapentin.","section":"mechanism","tier":"speculative","source_ids":["s23"],"source_status":"sourced","why_material":"Materialized from orphan source s23 by ledger repair"},{"id":"c28","text":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","section":"disclaimer","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Required constitution slot: disclaimer"},{"id":"c29","text":"There is no information on the long-term effects or safety of ARA-290 in human studies.","section":"what_is_unknown","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"This claim addresses a gap in the ledger regarding the long-term effects and safety of ARA-290, which is not covered by the existing sources."},{"id":"c30","text":"Anecdotal reports do not specify the duration of ARA-290 treatment before observing effects.","section":"who_claims_what","tier":"anecdotal","source_ids":["s5","s6","s15","s17","s18","s19"],"source_status":"sourced","why_material":"This claim fills a gap by summarizing a common limitation across several anecdotal reports, which do not provide details on the treatment duration."},{"id":"c31","text":"There is no information on the long-term effects or safety of ARA-290 compared to gabapentin or pregabalin.","section":"what_is_unknown","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"This claim identifies a specific gap in the ledger regarding the long-term effects and safety of ARA-290 compared to other treatments, which is not covered in the existing claims."},{"id":"c33","text":"The long-term implications of ARA-290's nerve repair mechanism versus gabapentin and pregabalin's signal suppression for patient outcomes are not fully understood.","section":"what_is_unknown","tier":"human","source_ids":["s2","s1","s4"],"source_status":"sourced","why_material":"Highlights a critical gap in understanding the comparative long-term clinical significance of the distinct mechanisms of action."},{"id":"c34","text":"A medical source provides general information regarding ARA-290 peptide for neuropathy and neurodegeneration.","section":"what_is_known","tier":"human","source_ids":["s8"],"source_status":"sourced","why_material":"Introduces a general medical perspective on ARA-290 from an unused source, broadening the context of available information."},{"id":"c35","text":"A review article discusses pregabalin and gabapentin in the context of treating neuropathic pain.","section":"mechanism","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Provides foundational context on the comparator drugs (gabapentin and pregabalin) from a scientific review, enriching the background information."},{"id":"c_map_ara-290-gabapentin-lyric","text":"Combinatorial mapping (transparent): ara-290 vs gabapentin-lyrica — regen=0.59, degen=0.6, Δ=-0.01. Method: layer_relevance(0.60) × evidence_factor(0.85); catalog.degen_score for Gabapentin / pregabalin.","section":"what_is_known","tier":"system","source_ids":[],"source_status":"unsourced"},{"id":"c36","text":"User considering ARA-290 as addition or alternative for diabetic neuropathy where gabapentin provides partial relief; anecdotal interest in peptide dosing/administration.","section":"who_claims_what","tier":"anecdotal","source_ids":["s25"],"source_status":"sourced","why_material":"Materialized from orphan source s25 by ledger repair"},{"id":"c37","text":"Post contrasts ARA-290 (nerve repair via innate repair receptor) with gabapentin/pregabalin (symptom masking only); includes dosing/timeline anecdotes labeled as not medical advice.","section":"who_claims_what","tier":"anecdotal","source_ids":["s26"],"source_status":"sourced","why_material":"Materialized from orphan source s26 by ledger repair"},{"id":"c38","text":"User reports using gabapentin for long COVID-related SFN pain; comment suggests trying ARA-290 for potential repair; anecdotal.","section":"who_claims_what","tier":"anecdotal","source_ids":["s27"],"source_status":"sourced","why_material":"Materialized from orphan source s27 by ledger repair"},{"id":"c39","text":"X post compares gabapentin (masks pain) vs ARA-290 (repairs nerves); promotional but highlights mechanistic difference, anecdotal context for users.","section":"who_claims_what","tier":"anecdotal","source_ids":["s28"],"source_status":"sourced","why_material":"Materialized from orphan source s28 by ledger repair"},{"id":"c40","text":"X thread starter contrasts gabapentin/opioids (masking) with ARA-290 (repair); includes science refs, not advice.","section":"who_claims_what","tier":"anecdotal","source_ids":["s29"],"source_status":"sourced","why_material":"Materialized from orphan source s29 by ledger repair"},{"id":"c41","text":"X reply notes gabapentin masks while ARA-290 (and others) may repair nerves; anecdotal user experience mention.","section":"who_claims_what","tier":"anecdotal","source_ids":["s30"],"source_status":"sourced","why_material":"Materialized from orphan source s30 by ledger repair"},{"id":"c42","text":"X post suggests ARA-290 as option to taper off gabapentin; anecdotal alternatives list, labeled not medical advice.","section":"who_claims_what","tier":"anecdotal","source_ids":["s31"],"source_status":"sourced","why_material":"Materialized from orphan source s31 by ledger repair"}],"sources":[{"id":"s1","type":"review","url":"https://www.frontiersin.org/journals/pain-research/articles/10.3389/fpain.2024.1513597/full","title":"Pregabalin vs. gabapentin in the treatment of neuropathic pain","quote":"Both drugs bind to the α2δ subunit of calcium channels in neurons, but pregabalin exhibits greater affinity and potency in its binding","summary":"Mechanism review of gabapentinoids","claim_ids":["c1","c29","c31","c33","c35"]},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"In patients with sarcoidosis, ARA290 significantly improved neuropathic and autonomic symptoms... ARA290 treatment for 28 days initiated a regrowth of small nerve fibers in the cornea","summary":"Human trial summary on nerve fiber changes","claim_ids":["c2","c33"]},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/","title":"ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes","quote":"Subjects receiving ARA 290 exhibited an improvement in hemoglobin A(1c) (Hb A(1c)) and lipid profiles... Neuropathic symptoms as assessed by the PainDetect questionnaire improved significantly in the ARA 290 group","summary":"Phase 2 human trial results","claim_ids":["c2","c3"]},{"id":"s4","type":"review","url":"https://www.pharmacytimes.com/view/how-gabapentin-differs-from-pregabalin","title":"Gabapentin Differs From Pregabalin in Several Key Ways","quote":"Dizziness and somnolence are the most common side effects in both drugs (>20% seen in gabapentin). Confusion and peripheral edema have also been reported","summary":"Side effect profile from clinical data","claim_ids":["c5","c33"]},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/","title":"Effectiveness of ARA-290...My Assessment","quote":"So far, so good and my dosage for gabapentin, has gone down from 2400 mg/day to 800-1600 mg/day ... I am now completely off gabapentin ... I now no longer take gabapentin and my ARA290 is 4mg daily for a month and then I take a break.","summary":"User anecdotal report on r/smallfiberneuropathy describing reduced and eventual cessation of gabapentin while using ARA-290 protocol, with positive symptom improvements noted.","author":"","publisher":"","date":"","claim_ids":["c6","c30","c5"]},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1o33123/peptide_ara290/","title":"Peptide ARA-290","quote":"Has anyone tried the peptide ARA-290 . It has clinical evidence of helping to slow or stop neuropathy and allow nerves to heal.","summary":"Recent (2025) Reddit discussion in r/neuropathy on ARA-290 for neuropathy, including user experiences with dosing alongside gabapentin for allodynia control.","author":"","publisher":"","date":"","claim_ids":["c7","c30","c5"]},{"id":"s7","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT02039687","title":"Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms in Patients With Sarcoidosis","quote":"The purpose of this study is to determine whether ARA 290 , a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis ...","summary":"ClinicalTrials.gov entry for Phase 2 trial of ARA 290 in sarcoidosis-associated small fiber neuropathy, focusing on neuropathic symptoms (distinct from excluded PMCs).","author":"","publisher":"","date":"","claim_ids":["c5"]},{"id":"s8","type":"medical","url":"https://mindbodyneurology.com/ara-290-peptide-neuropathy/","title":"ARA 290 Peptide for Neuropathy and Neurodegeneration","quote":"Standard options such as duloxetine, gabapentin, pregabalin, and tricyclics still play a role for many patients. ARA 290 research points toward an adjunct that targets root mechanisms.","summary":"Integrative neurology site discusses ARA-290 as potential adjunct to gabapentinoids like gabapentin and pregabalin (Lyrica) for neuropathy, emphasizing regenerative vs symptomatic effects.","author":"","publisher":"","date":"","claim_ids":["c9","c34"]},{"id":"s9","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06626971","title":"The Use of ARA290 for the Treatment of Diabetic Macular Edema","quote":"ARA 290 is a drug that has marked anti-inflammatory properties and has an effect in preventing the death of cells. As inflammation is known to play a role in ...","summary":"New 2025-2026 clinical trial on ARA290 for diabetic macular edema, related to neuropathy/inflammation pathways.","author":"","publisher":"","date":"","claim_ids":["c5"]},{"id":"s10","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40216181/","title":"ARA290, an alternative of erythropoietin, inhibits activation ...","quote":"EPO and ARA290 promote repair and regeneration by inhibiting the activation of NLRP3 inflammasome after sciatic nerve injury.","summary":"2025 PubMed paper on ARA290 mechanism for nerve injury repair via NLRP3 inhibition.","author":"","publisher":"","date":"","claim_ids":["c11"]},{"id":"s11","type":"review","url":"https://journals.lww.com/painrpts/fulltext/2016/08000/targeting_the_innate_repair_receptor_to_treat.2.aspx","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","summary":"Review discussing ARA290 vs standard treatments like gabapentin in neuropathy context.","author":"","publisher":"","date":"","claim_ids":["c12"]},{"id":"s12","type":"medical","url":"https://bamapain.com/sciatica/","title":"Leg Pain & Sciatica Treatment Birmingham AL","quote":"Gabapentin reduces neuropathic leg pain by fifty percent in roughly one out of six patients . ARA-290 has the most advanced clinical evidence of any peptide for ...","summary":"Clinic site comparing ARA-290 evidence to gabapentin for neuropathic pain.","author":"","publisher":"","date":"","claim_ids":["c5"]},{"id":"s13","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/vlbxty/ara290_for_neuropathic_pain/","title":"ARA-290 for Neuropathic Pain","quote":"~ 50% improvement in my condition (length-dependent ・ a hint of peripheral nerve healing/regeneration.","summary":"Anecdotal report on ARA-290 effects, mentions cost vs standard meds.","author":"","publisher":"","date":"","claim_ids":["c14"]},{"id":"s14","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1tncdyo/ara290_peptide_and_rebuilder_2407_have_changed_my/","title":"ARA290 peptide AND Rebuilder 2407 have changed my life!","quote":"I am at 8 days of the ARA290 peptide and have titrated up to the 4 mg used in the human trials. ... Yesterday was by FAR the best day of the past 15 months!","summary":"Recent anecdotal user experience with ARA-290 for neuropathy pain.","author":"","publisher":"","date":"","claim_ids":["c15"]},{"id":"s15","type":"youtube","url":"https://www.youtube.com/watch?v=xggIEy1ZfM8","title":"Small Fiber Neuropathy and ARA-290 Results","quote":"ARA 290 is a potential therapy currently being researched for its safety and efficacy for the treatment of neuropathic pain in patients with sarcoidosis","summary":"Video discussing ARA-290 trials and comparison to GABA analogs like Neurontin/Lyrica.","author":"","publisher":"","date":"","claim_ids":["c16","c30","c5"]},{"id":"s16","type":"other","url":"https://peptidefox.com/content/ara-290","title":"ARA-290: Tissue-Protective Peptide for Nerve Pain","quote":"The strongest human data is narrow but real. In Phase 2 trials in sarcoidosis-associated small fiber neuropathy, and one trial in painful diabetic neuropathy, ARA-290 increased objective markers of small-nerve regeneration","summary":"Medical overview of ARA-290 evidence base vs conventional treatments.","author":"","publisher":"","date":"","claim_ids":["c5"]},{"id":"s17","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/hreepv/ara290_peptide_any_experience_reports/","title":"ARA-290 peptide — any experience reports? : r/neuropathy","quote":"I am almost done with a month of ara 290 . I'm not part of a trial but I am using it. It's not cheap. I have seen really great results. My ... I've tried everything you can imagine, from red light therapy, acupuncture, deep tissue massages, pregabalin, gabapentin etc. Unfortunately, when there is nerve damage there is very little one can do and I don't want to be on meds the rest of my life, not to mention they don't really work, at least for me.","summary":"User reports great results from one month of ARA-290 (non-trial, self-sourced, ~$500 cost), contrasting with ineffective pregabalin/gabapentin and other treatments for neuropathy; plans longer protocol with no side effects noted.","author":"","publisher":"","date":"","claim_ids":["c18","c30","c5"]},{"id":"s18","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1tvw5x6/ara290_disc_herniaton_nerve_pain/","title":"ARA-290 Disc Herniaton & Nerve Pain : r/neuropathy","quote":"I've started ARA-290 and I’m planning to run a 28-day cycle to see if it helps with my neuropathic pain. ... I tried pregabalin but it was horrible. ... UPDATE (07.06.2026) I had to take 2 days off from it as I was abroad and not able to take it with me. I was on it for less than a week and didn't notice any benefits nor side effects.","summary":"User with disc-related neuropathic pain (neck/arm) starting ARA-290 protocol (3.3-6mg/day) after pregabalin caused severe light-headedness; early update shows no benefits or side effects after <1 week.","author":"","publisher":"","date":"","claim_ids":["c19","c30","c5"]},{"id":"s19","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1kakzrn/reconstitute_ara290_in_nacl_09_instead_of_pbs/","title":"Reconstitute ARA-290 in NaCL 0.9% instead of PBS? : r/smallfiberneuropathy","quote":"I haven't seen any improvement after trying it for several months, hope it works for you","summary":"User comment reports no improvement from ARA-290 after several months of use for (implied) small fiber neuropathy.","author":"","publisher":"","date":"","claim_ids":["c20","c30","c5"]},{"id":"s20","type":"instagram","url":"https://www.instagram.com/reel/DVjz4bDDZJn/","title":"Instagram reel on ARA 290 for neuropathy vs Gabapentin/Lyrica","quote":"If you have neuropathy or chronic nerve pain, standard medicine tells you to “live with it” while prescribing Gabapentin or Lyrica. ... Enter ARA 290 (Cibinetide).","summary":"Compares ARA-290 favorably as a regenerative alternative to symptomatic treatments like Gabapentin or Lyrica, citing trial data on pain reduction and nerve repair.","author":"","publisher":"","date":"","claim_ids":["c21"]},{"id":"s21","type":"review","url":"https://www.nature.com/articles/s41392-025-02175-1","title":"Diabetic neuropathy: cutting-edge research and future ...","quote":"A double-blind, placebo-controlled, investigator-initiated clinical trial showed that ARA 290 benefited both metabolic control and neuropathic ... Current management strategies primarily focus on alleviating symptoms and controlling pain. [11] Antidepressants, anticonvulsants, and opioids have shown limited efficacy...","summary":"2025 review discusses ARA-290 benefits in diabetic neuropathy alongside limitations of standard anticonvulsants like gabapentinoids.","author":"","publisher":"","date":"","claim_ids":["c22"]},{"id":"s22","type":"other","url":"https://bcb.bme.gatech.edu/cgi-bin/crispr/news.cgi?p=2026-s-ara-290-peptide-craze-the-biohacking-movement-chronic-pain-patients-can-t-quit-6a1b07505f5d2","title":"The Biohacking Movement Chronic Pain Patients Can't Quit","quote":"The promise is seductive: a molecule that can repair nerves and extinguish inflammation without the classic side effects of gabapentin or the risks of opioids.","summary":"2026 article on biohacking trends positions ARA-290 as experimental alternative to gabapentin for chronic pain/neuropathy.","author":"","publisher":"","date":"","claim_ids":["c5"]},{"id":"s23","type":"medical","url":"https://www.seekpeptides.com/blog/articles/peptides-for-neuropathy","title":"the complete guide to nerve repair and pain relief","quote":"What sets ARA-290 apart mechanistically is that it does not simply mask pain . It reduces the underlying inflammation driving nerve damage and ... It is one of the few compounds with human evidence of nerve-fiber regeneration markers, rather than only symptom suppression like gabapentin or duloxetine.","summary":"2026 guide contrasts ARA-290's regenerative mechanism with symptom-masking drugs like gabapentin.","author":"","publisher":"","date":"","claim_ids":["c24"]},{"id":"s24","type":"medical","url":"https://www.bettermedspa.com/treatments/rewire-ara-290","title":"ReWire (ARA-290) Peptide Therapy Lincoln Park","quote":"For patients in Chicago dealing with neuropathic symptoms that have resisted gabapentin, pregabalin, or duloxetine, this mechanism offers a fundamentally different approach: rather than dulling pain signals, ReWire addresses the structural and inflammatory roots of nerve dysfunction.","summary":"Clinic site describes ARA-290 for patients unresponsive to gabapentin/pregabalin (Lyrica).","author":"","publisher":"","date":"","claim_ids":["c5"]},{"id":"s25","type":"reddit","url":"https://www.reddit.com/r/neuropathy/comments/1u9ikrk/how_do_you_administer_peptides/","title":"How do you administer peptides?","quote":"I’m thinking of getting ara290 for my husband who has diabetic neuropathy. Gabapentin helps him but the pain seems to still be worse at times, more so than say a year ago.","summary":"User considering ARA-290 as addition or alternative for diabetic neuropathy where gabapentin provides partial relief; anecdotal interest in peptide dosing/administration.","author":"","publisher":"","date":"","claim_ids":["c36"]},{"id":"s26","type":"reddit","url":"https://www.reddit.com/r/Biohack_Blueprint/comments/1qf1t16/nerve_damage_wont_heal_ara290_complete_guide/","title":"Nerve Damage Won't Heal → ARA-290 Complete Guide","quote":"Most neuropathy treatments work downstream. Gabapentin and pregabalin modulate calcium channels to reduce pain signaling.","summary":"Post contrasts ARA-290 (nerve repair via innate repair receptor) with gabapentin/pregabalin (symptom masking only); includes dosing/timeline anecdotes labeled as not medical advice.","author":"","publisher":"","date":"","claim_ids":["c37"]},{"id":"s27","type":"reddit","url":"https://www.reddit.com/r/smallfiberneuropathy/comments/1fei315/any_success_at_easing_nerve_damage_from_longcovid/","title":"Any success at easing nerve damage from longcovid?","quote":"I have to go on Gabapentin and Duloxetine to stop the severe burning pain. ... I would look into ARA 290.","summary":"User reports using gabapentin for long COVID-related SFN pain; comment suggests trying ARA-290 for potential repair; anecdotal.","author":"","publisher":"","date":"","claim_ids":["c38"]},{"id":"s28","type":"x","url":"https://x.com/PeptidesFinder/status/2047760738371125595","title":"","quote":"Nerve pain is usually treated with drugs that just numb your brain (Gabapentin). They mask the signal. They don't fix the wire. You need something that targets the \"Innate Repair Receptor.\" Meet ARA-290 (The Nerve Healer). It stops the pain and regrows the fiber.","summary":"X post compares gabapentin (masks pain) vs ARA-290 (repairs nerves); promotional but highlights mechanistic difference, anecdotal context for users.","author":"","publisher":"","date":"","claim_ids":["c39"]},{"id":"s29","type":"x","url":"https://x.com/PeptidesFinder/status/2039040304800571738","title":"","quote":"Chronic pain (Neuropathy) is usually treated with gabapentin or opioids. These drugs act like \"volume knobs\"—they turn down the signal, but the wire stays broken. Science has found a peptide designed to physically repair the wire. Meet ARA-290 (Cibinetide).","summary":"X thread starter contrasts gabapentin/opioids (masking) with ARA-290 (repair); includes science refs, not advice.","author":"","publisher":"","date":"","claim_ids":["c40"]},{"id":"s30","type":"x","url":"https://x.com/Zedzies/status/2019107972837003451","title":"","quote":"And those small nerves just don’t innervate skin. They innervate other organs as well. ARA-290 Erinacine (Lions mane) Psilocybin All can regrow/repair. Gabapentin only masks.","summary":"X reply notes gabapentin masks while ARA-290 (and others) may repair nerves; anecdotal user experience mention.","author":"","publisher":"","date":"","claim_ids":["c41"]},{"id":"s31","type":"x","url":"https://x.com/BOENGLISH1/status/1912566621115486518","title":"","quote":"There are quite a few therapies which could help people get off gabapentin and similar drugs: ara-290, NA R-ALA, hyperbaric O2, and red light therapy","summary":"X post suggests ARA-290 as option to taper off gabapentin; anecdotal alternatives list, labeled not medical advice.","author":"","publisher":"","date":"","claim_ids":["c42"]}],"prov":{"model":"grok/grok-4.3","action":"write"}}